Login | Register
Profile | Log out
logo

  • Home
  • News
  • Opinion
  • Other
    • Market Updates
    • Explainers
    • Satire
  • About
  • Contact Us
    • Contact
    • Get Covered
    • Posting Guidelines
  • Subscribe
Submit An Article

4DX

  • Home
  •  
  • 4DX



  • Most Read
  • Latest Comments
  • 4D Medical commences trading on the ASX, opens at 2x IPO Price
    • News

    RBA and ASIC up the ante on blockchain project, ASX writes off millions
    Public
  • 4D Medical commences trading on the ASX, opens at 2x IPO Price
    • News

    AV uptake leads Audinate to push European expansion through recruiting drive
    Public
  • 4D Medical commences trading on the ASX, opens at 2x IPO Price
    • Opinion

    What the SportsBet-BetEasy merger means for TabCorp and punters
    Public
  • 4D Medical commences trading on the ASX, opens at 2x IPO Price
    • News

    Why this Tasmanian whisky brand had a record sales quarter
    Public
  • 4D Medical commences trading on the ASX, opens at 2x IPO Price
    Tremors from the FTX collapse continue to be felt as DigitalX sells off 15% Bitcoin holdings
    • Review
    • January 10, 2023
  • Opening a new frontier in treating Parkinson’s disease
    • Review
    • November 11, 2022
  • AUDC stablecoin gathers momentum as Novatti confirms integration with XRP Ledger
    • Review
    • June 9, 2022
  • PharmAust completes dosing first cohort for MND treatment, patients respond positively
    • Review
    • January 6, 2023
  • Is this the most hated company on the ASX?
    • Review
    • August 16, 2019

Latest Articles

  • 4DMedical Secures U.S. Deal with Intermountain Health, Unlocking Growth Path
    4DMedical Secures U.S. Deal with Intermountain Health, Unlocking Growth Path
    • News

  • PainChek locks in performance data for FDA submission, aiming to be  first pain assessment app approved in US
    PainChek locks in performance data for FDA submission, aiming to be first pain assessment app approved in US
    • News

  • HeraMED eyes TGA reclassification to restore HeraBEAT device for at-home use
    HeraMED eyes TGA reclassification to restore HeraBEAT device for at-home use
    • News

  • Nido Education flags profit downgrade amid delays in new childcare centre openings
    Nido Education flags profit downgrade amid delays in new childcare centre openings
    • News

  • dorsaVi secures $110k in contracts across mining, healthcare, and shipping sectors
    dorsaVi secures $110k in contracts across mining, healthcare, and shipping sectors
    • News

  • 4D Medical commences trading on the ASX, opens at 2x IPO Price
    • News

    4D Medical commences trading on the ASX, opens at 2x IPO Price

    Investors that missed out on the IPO for medtech company 4D Medical (ASX: 4DX) have had no qualms buying the stock on market with shares in 4DX opening at $1.47 when trading commenced this morning, more than double the IPO Offer Price of $0.73.  The significant jump follows a similar trend among Australian investors that

    Read More
    Public
  • IPO Watch August: 4D Medical
    • News

    IPO Watch August: 4D Medical

    While the number of companies set to list on the ASX is still quieter than usual, we are continuing to see many healthcare companies viewing COVID-19 as an opportunity to make their public debut.  4D Medical are a Melbourne-based medical technology company, who have spent the last 15 years developing lung imaging software. The ‘software

    Read More
    Public
  • 1
  • 2

Login or register for free to access unlimited reading

Register Now!
  • News

  • Opinion

  • Satire

  • About

  • Contact Us

  • Subscribe

The content published on this website is solely for general information purposes and is not to be construed as financial advice. Should you seek financial advice you should consult with an appropriately qualified person. Opinions expressed on this site are subject to change without notice and The Sentiment who produced this content is under no obligation to keep the information current. The Sentiment, affiliated companies & associates may have a conflict of interest with companies discussed on the website due to commercial arrangements, for example they may be shareholders in the company, be engaged by them to assist in investor communications or receive commission/brokerage for funds raised.

Copyright © 2020 The Sentiment. All rights reserved.
Subscribe

Enter your email address below to subscribe to The Sentiment’s weekly newsletter, highlighting the top news, research, opinion and satire articles shaping ASX investor sentiment.

The Sentiment respects your privacy and will not spam you. View our privacy policy here.